Personalized medicine breakthrough: Lab-Grown Mini-Guts guide treatment for rare CF cases
Disease control
Completed
This study tested whether a three-drug combination (Dirocaftor/Posenacaftor/Nesolicaftor) could help adults with cystic fibrosis who have rare genetic mutations not covered by existing treatments. Researchers first used patients' own lab-grown intestinal tissue samples to predict…
Phase: PHASE2 • Sponsor: Kors van der Ent • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC